img

Global Vials for COVID-19 Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Packaging

Publisher : MRA | Format : PDF

Global Vials for COVID-19 Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

The global Vials for COVID-19 Vaccine market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during the forecast period 2023-2029.
The United States market for Vials for COVID-19 Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Vials for COVID-19 Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Vials for COVID-19 Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029..
The global key manufacturers of Vials for COVID-19 Vaccine include Corning, Schott AG, SiO2 Materials Science, SGD Pharma, Stevanato Group, DWK Life Sciences and Gerresheimer, etc. In 2022, the global top five players hold a share approximately % in sales volume, and in term of revenue of Vials for COVID-19 Vaccine, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Vials for COVID-19 Vaccine by regions (Countries), company, by type and by type. from 2018 to 2023 and forecast to 2029.
The global Vials for COVID-19 Vaccine market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Vials for COVID-19 Vaccine market. These figures have been provided in terms of both revenue and sales for the period 2018-2029. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Corning
Schott AG
SiO2 Materials Science
SGD Pharma
Stevanato Group
DWK Life Sciences
Gerresheimer
By Type
Middle-borate Borosilicate Glass
Low-borate Borosilicate Glass
By Application
Vaccine Manufacturing
Vaccine Researching
Sales by Region
North America
United States
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Vials for COVID-19 Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Vials for COVID-19 Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Vials for COVID-19 Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Vials for COVID-19 Vaccine Definition
1.2 Market by Type
1.2.1 Global Vials for COVID-19 Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Middle-borate Borosilicate Glass
1.2.3 Low-borate Borosilicate Glass
1.3 Market Segment by Application
1.3.1 Global Vials for COVID-19 Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Vaccine Manufacturing
1.3.3 Vaccine Researching
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Vials for COVID-19 Vaccine Sales
2.1 Global Vials for COVID-19 Vaccine Revenue Estimates and Forecasts 2018-2029
2.2 Global Vials for COVID-19 Vaccine Revenue by Region: 2018 VS 2022 VS 2029
2.3 Global Vials for COVID-19 Vaccine Revenue by Region
2.3.1 Global Vials for COVID-19 Vaccine Revenue by Region (2018-2023)
2.3.2 Global Vials for COVID-19 Vaccine Revenue by Region (2024-2029)
2.4 Global Vials for COVID-19 Vaccine Sales Quantity Estimates and Forecasts 2018-2029
2.5 Global Vials for COVID-19 Vaccine Sales Quantity by Region: 2018 VS 2022 VS 2029
2.6 Global Vials for COVID-19 Vaccine Sales Quantity by Region
2.6.1 Global Vials for COVID-19 Vaccine Sales Quantity by Region (2018-2023)
2.6.2 Global Vials for COVID-19 Vaccine Sales Quantity by Region (2024-2029)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Vials for COVID-19 Vaccine Sales Quantity by Manufacturers
3.1.1 Global Vials for COVID-19 Vaccine Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Vials for COVID-19 Vaccine Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Vials for COVID-19 Vaccine Sales in 2022
3.2 Global Vials for COVID-19 Vaccine Revenue by Manufacturers
3.2.1 Global Vials for COVID-19 Vaccine Revenue by Manufacturers (2018-2023)
3.2.2 Global Vials for COVID-19 Vaccine Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Vials for COVID-19 Vaccine Revenue in 2022
3.3 Global Vials for COVID-19 Vaccine Sales Price by Manufacturers
3.4 Global Key Players of Vials for COVID-19 Vaccine, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Vials for COVID-19 Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Vials for COVID-19 Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Vials for COVID-19 Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Vials for COVID-19 Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Vials for COVID-19 Vaccine Sales Quantity by Type
4.1.1 Global Vials for COVID-19 Vaccine Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Vials for COVID-19 Vaccine Forecasted Sales Quantity by Type (2024-2029)
4.1.3 Global Vials for COVID-19 Vaccine Sales Quantity Market Share by Type (2018-2029)
4.2 Global Vials for COVID-19 Vaccine Revenue by Type
4.2.1 Global Vials for COVID-19 Vaccine Historical Revenue by Type (2018-2023)
4.2.2 Global Vials for COVID-19 Vaccine Forecasted Revenue by Type (2024-2029)
4.2.3 Global Vials for COVID-19 Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Vials for COVID-19 Vaccine Price by Type
4.3.1 Global Vials for COVID-19 Vaccine Price by Type (2018-2023)
4.3.2 Global Vials for COVID-19 Vaccine Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Vials for COVID-19 Vaccine Sales Quantity by Application
5.1.1 Global Vials for COVID-19 Vaccine Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Vials for COVID-19 Vaccine Forecasted Sales Quantity by Application (2024-2029)
5.1.3 Global Vials for COVID-19 Vaccine Sales Quantity Market Share by Application (2018-2029)
5.2 Global Vials for COVID-19 Vaccine Revenue by Application
5.2.1 Global Vials for COVID-19 Vaccine Historical Revenue by Application (2018-2023)
5.2.2 Global Vials for COVID-19 Vaccine Forecasted Revenue by Application (2024-2029)
5.2.3 Global Vials for COVID-19 Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Vials for COVID-19 Vaccine Price by Application
5.3.1 Global Vials for COVID-19 Vaccine Price by Application (2018-2023)
5.3.2 Global Vials for COVID-19 Vaccine Price Forecast by Application (2024-2029)
6 North America
6.1 North America Vials for COVID-19 Vaccine Sales by Company
6.1.1 North America Vials for COVID-19 Vaccine Revenue by Company (2018-2023)
6.1.2 North America Vials for COVID-19 Vaccine Sales Quantity by Company (2018-2023)
6.2 North America Vials for COVID-19 Vaccine Market Size by Type
6.2.1 North America Vials for COVID-19 Vaccine Sales Quantity by Type (2018-2029)
6.2.2 North America Vials for COVID-19 Vaccine Revenue by Type (2018-2029)
6.3 North America Vials for COVID-19 Vaccine Market Size by Application
6.3.1 North America Vials for COVID-19 Vaccine Sales Quantity by Application (2018-2029)
6.3.2 North America Vials for COVID-19 Vaccine Revenue by Application (2018-2029)
6.4 North America Vials for COVID-19 Vaccine Market Size by Country
6.4.1 North America Vials for COVID-19 Vaccine Revenue by Country: 2018 VS 2022 VS 2029
6.4.2 North America Vials for COVID-19 Vaccine Revenue by Country (2018-2029)
6.4.3 North America Vials for COVID-19 Vaccine Sales Quantity by Country (2018-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Vials for COVID-19 Vaccine Sales by Company
7.1.1 Europe Vials for COVID-19 Vaccine Sales Quantity by Company (2018-2023)
7.1.2 Europe Vials for COVID-19 Vaccine Revenue by Company (2018-2023)
7.2 Europe Vials for COVID-19 Vaccine Market Size by Type
7.2.1 Europe Vials for COVID-19 Vaccine Sales Quantity by Type (2018-2029)
7.2.2 Europe Vials for COVID-19 Vaccine Revenue by Type (2018-2029)
7.3 Europe Vials for COVID-19 Vaccine Market Size by Application
7.3.1 Europe Vials for COVID-19 Vaccine Sales Quantity by Application (2018-2029)
7.3.2 Europe Vials for COVID-19 Vaccine Revenue by Application (2018-2029)
7.4 Europe Vials for COVID-19 Vaccine Market Size by Country
7.4.1 Europe Vials for COVID-19 Vaccine Revenue by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Vials for COVID-19 Vaccine Revenue by Country (2018-2029)
7.4.3 Europe Vials for COVID-19 Vaccine Sales Quantity by Country (2018-2029)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Vials for COVID-19 Vaccine Sales by Company
8.1.1 China Vials for COVID-19 Vaccine Sales Quantity by Company (2018-2023)
8.1.2 China Vials for COVID-19 Vaccine Revenue by Company (2018-2023)
8.2 China Vials for COVID-19 Vaccine Market Size by Type
8.2.1 China Vials for COVID-19 Vaccine Sales Quantity by Type (2018-2029)
8.2.2 China Vials for COVID-19 Vaccine Revenue by Type (2018-2029)
8.3 China Vials for COVID-19 Vaccine Market Size by Application
8.3.1 China Vials for COVID-19 Vaccine Sales Quantity by Application (2018-2029)
8.3.2 China Vials for COVID-19 Vaccine Revenue by Application (2018-2029)
9 APAC (excluding China)
9.1 APAC Vials for COVID-19 Vaccine Sales by Company
9.1.1 APAC Vials for COVID-19 Vaccine Sales Quantity by Company (2018-2023)
9.1.2 APAC Vials for COVID-19 Vaccine Revenue by Company (2018-2023)
9.2 APAC Vials for COVID-19 Vaccine Market Size by Type
9.2.1 APAC Vials for COVID-19 Vaccine Sales Quantity by Type (2018-2029)
9.2.2 APAC Vials for COVID-19 Vaccine Revenue by Type (2018-2029)
9.3 APAC Vials for COVID-19 Vaccine Market Size by Application
9.3.1 APAC Vials for COVID-19 Vaccine Sales Quantity by Application (2018-2029)
9.3.2 APAC Vials for COVID-19 Vaccine Revenue by Application (2018-2029)
9.4 APAC Vials for COVID-19 Vaccine Market Size by Region
9.4.1 APAC Vials for COVID-19 Vaccine Revenue by Region: 2018 VS 2022 VS 2029
9.4.2 APAC Vials for COVID-19 Vaccine Revenue by Region (2018-2029)
9.4.3 APAC Vials for COVID-19 Vaccine Sales Quantity by Region (2018-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Vials for COVID-19 Vaccine Sales by Company
10.1.1 Middle East, Africa and Latin America Vials for COVID-19 Vaccine Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Vials for COVID-19 Vaccine Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Vials for COVID-19 Vaccine Market Size by Type
10.2.1 Middle East, Africa and Latin America Vials for COVID-19 Vaccine Sales Quantity by Type (2018-2029)
10.2.2 Middle East, Africa and Latin America Vials for COVID-19 Vaccine Revenue by Type (2018-2029)
10.3 Middle East, Africa and Latin America Vials for COVID-19 Vaccine Market Size by Application
10.3.1 Middle East, Africa and Latin America Vials for COVID-19 Vaccine Sales Quantity by Application (2018-2029)
10.3.2 Middle East, Africa and Latin America Vials for COVID-19 Vaccine Revenue by Application (2018-2029)
10.4 Middle East, Africa and Latin America Vials for COVID-19 Vaccine Market Size by Country
10.4.1 Middle East, Africa and Latin America Vials for COVID-19 Vaccine Revenue by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa and Latin America Vials for COVID-19 Vaccine Revenue by Country (2018-2029)
10.4.3 Middle East, Africa and Latin America Vials for COVID-19 Vaccine Sales Quantity by Country (2018-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Corning
11.1.1 Corning Company Information
11.1.2 Corning Overview
11.1.3 Corning Vials for COVID-19 Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Corning Vials for COVID-19 Vaccine Products and Services
11.1.5 Corning Vials for COVID-19 Vaccine SWOT Analysis
11.1.6 Corning Recent Developments
11.2 Schott AG
11.2.1 Schott AG Company Information
11.2.2 Schott AG Overview
11.2.3 Schott AG Vials for COVID-19 Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Schott AG Vials for COVID-19 Vaccine Products and Services
11.2.5 Schott AG Vials for COVID-19 Vaccine SWOT Analysis
11.2.6 Schott AG Recent Developments
11.3 SiO2 Materials Science
11.3.1 SiO2 Materials Science Company Information
11.3.2 SiO2 Materials Science Overview
11.3.3 SiO2 Materials Science Vials for COVID-19 Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 SiO2 Materials Science Vials for COVID-19 Vaccine Products and Services
11.3.5 SiO2 Materials Science Vials for COVID-19 Vaccine SWOT Analysis
11.3.6 SiO2 Materials Science Recent Developments
11.4 SGD Pharma
11.4.1 SGD Pharma Company Information
11.4.2 SGD Pharma Overview
11.4.3 SGD Pharma Vials for COVID-19 Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 SGD Pharma Vials for COVID-19 Vaccine Products and Services
11.4.5 SGD Pharma Vials for COVID-19 Vaccine SWOT Analysis
11.4.6 SGD Pharma Recent Developments
11.5 Stevanato Group
11.5.1 Stevanato Group Company Information
11.5.2 Stevanato Group Overview
11.5.3 Stevanato Group Vials for COVID-19 Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Stevanato Group Vials for COVID-19 Vaccine Products and Services
11.5.5 Stevanato Group Vials for COVID-19 Vaccine SWOT Analysis
11.5.6 Stevanato Group Recent Developments
11.6 DWK Life Sciences
11.6.1 DWK Life Sciences Company Information
11.6.2 DWK Life Sciences Overview
11.6.3 DWK Life Sciences Vials for COVID-19 Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 DWK Life Sciences Vials for COVID-19 Vaccine Products and Services
11.6.5 DWK Life Sciences Vials for COVID-19 Vaccine SWOT Analysis
11.6.6 DWK Life Sciences Recent Developments
11.7 Gerresheimer
11.7.1 Gerresheimer Company Information
11.7.2 Gerresheimer Overview
11.7.3 Gerresheimer Vials for COVID-19 Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 Gerresheimer Vials for COVID-19 Vaccine Products and Services
11.7.5 Gerresheimer Vials for COVID-19 Vaccine SWOT Analysis
11.7.6 Gerresheimer Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Vials for COVID-19 Vaccine Value Chain Analysis
12.2 Vials for COVID-19 Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Vials for COVID-19 Vaccine Production Mode & Process
12.4 Vials for COVID-19 Vaccine Sales and Marketing
12.4.1 Vials for COVID-19 Vaccine Sales Channels
12.4.2 Vials for COVID-19 Vaccine Distributors
12.5 Vials for COVID-19 Vaccine Customers
13 Market Dynamics
13.1 Vials for COVID-19 Vaccine Industry Trends
13.2 Vials for COVID-19 Vaccine Market Drivers
13.3 Vials for COVID-19 Vaccine Market Challenges
13.4 Vials for COVID-19 Vaccine Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Vials for COVID-19 Vaccine Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Middle-borate Borosilicate Glass
Table 3. Major Manufacturers of Low-borate Borosilicate Glass
Table 4. Global Vials for COVID-19 Vaccine Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Vials for COVID-19 Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Vials for COVID-19 Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 7. Global Vials for COVID-19 Vaccine Revenue Market Share by Region (2018-2023)
Table 8. Global Vials for COVID-19 Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Vials for COVID-19 Vaccine Revenue Market Share by Region (2024-2029)
Table 10. Global Vials for COVID-19 Vaccine Sales Quantity by Region: 2018 VS 2022 VS 2029 (Million Units)
Table 11. Global Vials for COVID-19 Vaccine Sales by Region (2018-2023) & (Million Units)
Table 12. Global Vials for COVID-19 Vaccine Sales Market Share by Region (2018-2023)
Table 13. Global Vials for COVID-19 Vaccine Sales by Region (2024-2029) & (Million Units)
Table 14. Global Vials for COVID-19 Vaccine Sales Market Share by Region (2024-2029)
Table 15. Global Vials for COVID-19 Vaccine Sales Quantity by Manufacturers (2018-2023) & (Million Units)
Table 16. Global Vials for COVID-19 Vaccine Sales Quantity Share by Manufacturers (2018-2023)
Table 17. Global Vials for COVID-19 Vaccine Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 18. Global Vials for COVID-19 Vaccine Revenue Share by Manufacturers (2018-2023)
Table 19. Global Vials for COVID-19 Vaccine Price by Manufacturers 2018-2023 (US$/K Units)
Table 20. Global Key Players of Vials for COVID-19 Vaccine, Industry Ranking, 2021 VS 2022
Table 21. Global Vials for COVID-19 Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Vials for COVID-19 Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vials for COVID-19 Vaccine as of 2022)
Table 23. Global Key Manufacturers of Vials for COVID-19 Vaccine, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Vials for COVID-19 Vaccine, Product Offered and Application
Table 25. Global Key Manufacturers of Vials for COVID-19 Vaccine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Vials for COVID-19 Vaccine Sales Quantity by Type (2018-2023) & (Million Units)
Table 28. Global Vials for COVID-19 Vaccine Sales Quantity by Type (2024-2029) & (Million Units)
Table 29. Global Vials for COVID-19 Vaccine Sales Quantity Share by Type (2018-2023)
Table 30. Global Vials for COVID-19 Vaccine Sales Quantity Share by Type (2024-2029)
Table 31. Global Vials for COVID-19 Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 32. Global Vials for COVID-19 Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Vials for COVID-19 Vaccine Revenue Share by Type (2018-2023)
Table 34. Global Vials for COVID-19 Vaccine Revenue Share by Type (2024-2029)
Table 35. Vials for COVID-19 Vaccine Price by Type (2018-2023) & (US$/K Units)
Table 36. Global Vials for COVID-19 Vaccine Price Forecast by Type (2024-2029) & (US$/K Units)
Table 37. Global Vials for COVID-19 Vaccine Sales Quantity by Application (2018-2023) & (Million Units)
Table 38. Global Vials for COVID-19 Vaccine Sales Quantity by Application (2024-2029) & (Million Units)
Table 39. Global Vials for COVID-19 Vaccine Sales Quantity Share by Application (2018-2023)
Table 40. Global Vials for COVID-19 Vaccine Sales Quantity Share by Application (2024-2029)
Table 41. Global Vials for COVID-19 Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 42. Global Vials for COVID-19 Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Vials for COVID-19 Vaccine Revenue Share by Application (2018-2023)
Table 44. Global Vials for COVID-19 Vaccine Revenue Share by Application (2024-2029)
Table 45. Vials for COVID-19 Vaccine Price by Application (2018-2023) & (US$/K Units)
Table 46. Global Vials for COVID-19 Vaccine Price Forecast by Application (2024-2029) & (US$/K Units)
Table 47. North America Vials for COVID-19 Vaccine Revenue by Company (2018-2023) & (US$ Million)
Table 48. North America Vials for COVID-19 Vaccine Sales Quantity by Company (2018-2023) & (Million Units)
Table 49. North America Vials for COVID-19 Vaccine Sales Quantity by Type (2018-2023) & (Million Units)
Table 50. North America Vials for COVID-19 Vaccine Sales Quantity by Type (2024-2029) & (Million Units)
Table 51. North America Vials for COVID-19 Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 52. North America Vials for COVID-19 Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 53. North America Vials for COVID-19 Vaccine Sales Quantity by Application (2018-2023) & (Million Units)
Table 54. North America Vials for COVID-19 Vaccine Sales Quantity by Application (2024-2029) & (Million Units)
Table 55. North America Vials for COVID-19 Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 56. North America Vials for COVID-19 Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 57. North America Vials for COVID-19 Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. North America Vials for COVID-19 Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 59. North America Vials for COVID-19 Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 60. North America Vials for COVID-19 Vaccine Sales Quantity by Country (2018-2023) & (Million Units)
Table 61. North America Vials for COVID-19 Vaccine Sales Quantity by Country (2024-2029) & (Million Units)
Table 62. Europe Vials for COVID-19 Vaccine Sales Quantity by Company (2018-2023) & (Million Units)
Table 63. Europe Vials for COVID-19 Vaccine Revenue by Company (2018-2023) & (US$ Million)
Table 64. Europe Vials for COVID-19 Vaccine Sales Quantity by Type (2018-2023) & (Million Units)
Table 65. Europe Vials for COVID-19 Vaccine Sales Quantity by Type (2024-2029) & (Million Units)
Table 66. Europe Vials for COVID-19 Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 67. Europe Vials for COVID-19 Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 68. Europe Vials for COVID-19 Vaccine Sales Quantity by Application (2018-2023) & (Million Units)
Table 69. Europe Vials for COVID-19 Vaccine Sales Quantity by Application (2024-2029) & (Million Units)
Table 70. Europe Vials for COVID-19 Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 71. Europe Vials for COVID-19 Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 72. Europe Vials for COVID-19 Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 73. Europe Vials for COVID-19 Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 74. Europe Vials for COVID-19 Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 75. Europe Vials for COVID-19 Vaccine Sales Quantity by Country (2018-2023) & (Million Units)
Table 76. Europe Vials for COVID-19 Vaccine Sales Quantity by Country (2024-2029) & (Million Units)
Table 77. China Vials for COVID-19 Vaccine Sales Quantity by Company (2018-2023) & (Million Units)
Table 78. China Vials for COVID-19 Vaccine Revenue by Company (2018-2023) & (US$ Million)
Table 79. China Vials for COVID-19 Vaccine Sales Quantity by Type (2018-2023) & (Million Units)
Table 80. China Vials for COVID-19 Vaccine Sales Quantity by Type (2024-2029) & (Million Units)
Table 81. China Vials for COVID-19 Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 82. China Vials for COVID-19 Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 83. China Vials for COVID-19 Vaccine Sales Quantity by Application (2018-2023) & (Million Units)
Table 84. China Vials for COVID-19 Vaccine Sales Quantity by Application (2024-2029) & (Million Units)
Table 85. China Vials for COVID-19 Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 86. China Vials for COVID-19 Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 87. APAC Vials for COVID-19 Vaccine Sales Quantity by Company (2018-2023) & (Million Units)
Table 88. APAC Vials for COVID-19 Vaccine Revenue by Company (2018-2023) & (US$ Million)
Table 89. APAC Vials for COVID-19 Vaccine Sales Quantity by Type (2018-2023) & (Million Units)
Table 90. APAC Vials for COVID-19 Vaccine Sales Quantity by Type (2024-2029) & (Million Units)
Table 91. APAC Vials for COVID-19 Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 92. APAC Vials for COVID-19 Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 93. APAC Vials for COVID-19 Vaccine Sales Quantity by Application (2018-2023) & (Million Units)
Table 94. APAC Vials for COVID-19 Vaccine Sales Quantity by Application (2024-2029) & (Million Units)
Table 95. APAC Vials for COVID-19 Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 96. APAC Vials for COVID-19 Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 97. APAC Vials for COVID-19 Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 98. APAC Vials for COVID-19 Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 99. APAC Vials for COVID-19 Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 100. APAC Vials for COVID-19 Vaccine Sales Quantity by Region (2018-2023) & (Million Units)
Table 101. APAC Vials for COVID-19 Vaccine Sales Quantity by Region (2024-2029) & (Million Units)
Table 102. Middle East, Africa and Latin America Vials for COVID-19 Vaccine Sales Quantity by Company (2018-2023) & (Million Units)
Table 103. Middle East, Africa and Latin America Vials for COVID-19 Vaccine Revenue by Company (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America Vials for COVID-19 Vaccine Sales Quantity by Type (2018-2023) & (Million Units)
Table 105. Middle East, Africa and Latin America Vials for COVID-19 Vaccine Sales Quantity by Type (2024-2029) & (Million Units)
Table 106. Middle East, Africa and Latin America Vials for COVID-19 Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 107. Middle East, Africa and Latin America Vials for COVID-19 Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 108. Middle East, Africa and Latin America Vials for COVID-19 Vaccine Sales Quantity by Application (2018-2023) & (Million Units)
Table 109. Middle East, Africa and Latin America Vials for COVID-19 Vaccine Sales Quantity by Application (2024-2029) & (Million Units)
Table 110. Middle East, Africa and Latin America Vials for COVID-19 Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 111. Middle East, Africa and Latin America Vials for COVID-19 Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 112. Middle East, Africa and Latin America Vials for COVID-19 Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 113. Middle East, Africa and Latin America Vials for COVID-19 Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 114. Middle East, Africa and Latin America Vials for COVID-19 Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 115. Middle East, Africa and Latin America Vials for COVID-19 Vaccine Sales Quantity by Country (2018-2023) & (Million Units)
Table 116. Middle East, Africa and Latin America Vials for COVID-19 Vaccine Sales Quantity by Country (2024-2029) & (Million Units)
Table 117. Corning Company Information
Table 118. Corning Description and Overview
Table 119. Corning Vials for COVID-19 Vaccine Sales Quantity (Million Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/K Units) and Gross Margin (2018-2023)
Table 120. Corning Vials for COVID-19 Vaccine Product and Services
Table 121. Corning Vials for COVID-19 Vaccine SWOT Analysis
Table 122. Corning Recent Developments
Table 123. Schott AG Company Information
Table 124. Schott AG Description and Overview
Table 125. Schott AG Vials for COVID-19 Vaccine Sales Quantity (Million Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/K Units) and Gross Margin (2018-2023)
Table 126. Schott AG Vials for COVID-19 Vaccine Product and Services
Table 127. Schott AG Vials for COVID-19 Vaccine SWOT Analysis
Table 128. Schott AG Recent Developments
Table 129. SiO2 Materials Science Company Information
Table 130. SiO2 Materials Science Description and Overview
Table 131. SiO2 Materials Science Vials for COVID-19 Vaccine Sales Quantity (Million Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/K Units) and Gross Margin (2018-2023)
Table 132. SiO2 Materials Science Vials for COVID-19 Vaccine Product and Services
Table 133. SiO2 Materials Science Vials for COVID-19 Vaccine SWOT Analysis
Table 134. SiO2 Materials Science Recent Developments
Table 135. SGD Pharma Company Information
Table 136. SGD Pharma Description and Overview
Table 137. SGD Pharma Vials for COVID-19 Vaccine Sales Quantity (Million Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/K Units) and Gross Margin (2018-2023)
Table 138. SGD Pharma Vials for COVID-19 Vaccine Product and Services
Table 139. SGD Pharma Vials for COVID-19 Vaccine SWOT Analysis
Table 140. SGD Pharma Recent Developments
Table 141. Stevanato Group Company Information
Table 142. Stevanato Group Description and Overview
Table 143. Stevanato Group Vials for COVID-19 Vaccine Sales Quantity (Million Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/K Units) and Gross Margin (2018-2023)
Table 144. Stevanato Group Vials for COVID-19 Vaccine Product and Services
Table 145. Stevanato Group Vials for COVID-19 Vaccine SWOT Analysis
Table 146. Stevanato Group Recent Developments
Table 147. DWK Life Sciences Company Information
Table 148. DWK Life Sciences Description and Overview
Table 149. DWK Life Sciences Vials for COVID-19 Vaccine Sales Quantity (Million Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/K Units) and Gross Margin (2018-2023)
Table 150. DWK Life Sciences Vials for COVID-19 Vaccine Product and Services
Table 151. DWK Life Sciences Vials for COVID-19 Vaccine SWOT Analysis
Table 152. DWK Life Sciences Recent Developments
Table 153. Gerresheimer Company Information
Table 154. Gerresheimer Description and Overview
Table 155. Gerresheimer Vials for COVID-19 Vaccine Sales Quantity (Million Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/K Units) and Gross Margin (2018-2023)
Table 156. Gerresheimer Vials for COVID-19 Vaccine Product and Services
Table 157. Gerresheimer Vials for COVID-19 Vaccine SWOT Analysis
Table 158. Gerresheimer Recent Developments
Table 159. Key Raw Materials Lists
Table 160. Raw Materials Key Suppliers Lists
Table 161. Vials for COVID-19 Vaccine Distributors List
Table 162. Vials for COVID-19 Vaccine Customers List
Table 163. Vials for COVID-19 Vaccine Market Trends
Table 164. Vials for COVID-19 Vaccine Market Drivers
Table 165. Vials for COVID-19 Vaccine Market Challenges
Table 166. Vials for COVID-19 Vaccine Market Restraints
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Vials for COVID-19 Vaccine Product Picture
Figure 2. Global Vials for COVID-19 Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Vials for COVID-19 Vaccine Market Share by Type in 2022 & 2029
Figure 4. Middle-borate Borosilicate Glass Product Picture
Figure 5. Low-borate Borosilicate Glass Product Picture
Figure 6. Global Vials for COVID-19 Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Vials for COVID-19 Vaccine Market Share by Application in 2022 & 2029
Figure 8. Vaccine Manufacturing
Figure 9. Vaccine Researching
Figure 10. Vials for COVID-19 Vaccine Report Years Considered
Figure 11. Global Vials for COVID-19 Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Vials for COVID-19 Vaccine Revenue 2018-2029 (US$ Million)
Figure 13. Global Vials for COVID-19 Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Vials for COVID-19 Vaccine Sales Quantity 2018-2029 (Million Units)
Figure 15. Global Vials for COVID-19 Vaccine Sales Quantity Market Share by Region (2018-2023)
Figure 16. Global Vials for COVID-19 Vaccine Sales Quantity Market Share by Region (2024-2029)
Figure 17. North America Vials for COVID-19 Vaccine Sales Quantity YoY (2018-2029) & (Million Units)
Figure 18. North America Vials for COVID-19 Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Vials for COVID-19 Vaccine Sales Quantity YoY (2018-2029) & (Million Units)
Figure 20. Europe Vials for COVID-19 Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Vials for COVID-19 Vaccine Sales Quantity YoY (2018-2029) & (Million Units)
Figure 22. China Vials for COVID-19 Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 23. APAC Vials for COVID-19 Vaccine Sales Quantity YoY (2018-2029) & (Million Units)
Figure 24. APAC Vials for COVID-19 Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Vials for COVID-19 Vaccine Sales Quantity YoY (2018-2029) & (Million Units)
Figure 26. Middle East, Africa and Latin America Vials for COVID-19 Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Top 10 and Top 5 Players Market Share by Vials for COVID-19 Vaccine Sales Quantity in 2022
Figure 28. The Top 10 and Top 5 Players Market Share by Vials for COVID-19 Vaccine Revenue in 2022
Figure 29. Vials for COVID-19 Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Vials for COVID-19 Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 31. Global Vials for COVID-19 Vaccine Revenue Market Share by Type (2018-2029)
Figure 32. Global Vials for COVID-19 Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global Vials for COVID-19 Vaccine Revenue Market Share by Application (2018-2029)
Figure 34. North America Vials for COVID-19 Vaccine Revenue Market Share by Company in 2022
Figure 35. North America Vials for COVID-19 Vaccine Sales Quantity Market Share by Company in 2022
Figure 36. North America Vials for COVID-19 Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 37. North America Vials for COVID-19 Vaccine Revenue Market Share by Type (2018-2029)
Figure 38. North America Vials for COVID-19 Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 39. North America Vials for COVID-19 Vaccine Revenue Market Share by Application (2018-2029)
Figure 40. North America Vials for COVID-19 Vaccine Revenue Share by Country (2018-2029)
Figure 41. North America Vials for COVID-19 Vaccine Sales Quantity Share by Country (2018-2029)
Figure 42. United States Vials for COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 43. Canada Vials for COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 44. Europe Vials for COVID-19 Vaccine Sales Quantity Market Share by Company in 2022
Figure 45. Europe Vials for COVID-19 Vaccine Revenue Market Share by Company in 2022
Figure 46. Europe Vials for COVID-19 Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 47. Europe Vials for COVID-19 Vaccine Revenue Market Share by Type (2018-2029)
Figure 48. Europe Vials for COVID-19 Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 49. Europe Vials for COVID-19 Vaccine Revenue Market Share by Application (2018-2029)
Figure 50. Europe Vials for COVID-19 Vaccine Revenue Share by Country (2018-2029)
Figure 51. Europe Vials for COVID-19 Vaccine Sales Quantity Share by Country (2018-2029)
Figure 52. Germany Vials for COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 53. France Vials for COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 54. U.K. Vials for COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 55. Italy Vials for COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 56. Russia Vials for COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 57. China Vials for COVID-19 Vaccine Sales Quantity Market Share by Company in 2022
Figure 58. China Vials for COVID-19 Vaccine Revenue Market Share by Company in 2022
Figure 59. China Vials for COVID-19 Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 60. China Vials for COVID-19 Vaccine Revenue Market Share by Type (2018-2029)
Figure 61. China Vials for COVID-19 Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 62. China Vials for COVID-19 Vaccine Revenue Market Share by Application (2018-2029)
Figure 63. APAC Vials for COVID-19 Vaccine Sales Quantity Market Share by Company in 2022
Figure 64. APAC Vials for COVID-19 Vaccine Revenue Market Share by Company in 2022
Figure 65. APAC Vials for COVID-19 Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 66. APAC Vials for COVID-19 Vaccine Revenue Market Share by Type (2018-2029)
Figure 67. APAC Vials for COVID-19 Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 68. APAC Vials for COVID-19 Vaccine Revenue Market Share by Application (2018-2029)
Figure 69. APAC Vials for COVID-19 Vaccine Revenue Share by Region (2018-2029)
Figure 70. APAC Vials for COVID-19 Vaccine Sales Quantity Share by Region (2018-2029)
Figure 71. Japan Vials for COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 72. South Korea Vials for COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 73. China Taiwan Vials for COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 74. Southeast Asia Vials for COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 75. India Vials for COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 76. Middle East, Africa and Latin America Vials for COVID-19 Vaccine Sales Quantity Market Share by Company in 2022
Figure 77. Middle East, Africa and Latin America Vials for COVID-19 Vaccine Revenue Market Share by Company in 2022
Figure 78. Middle East, Africa and Latin America Vials for COVID-19 Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 79. Middle East, Africa and Latin America Vials for COVID-19 Vaccine Revenue Market Share by Type (2018-2029)
Figure 80. Middle East, Africa and Latin America Vials for COVID-19 Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 81. Middle East, Africa and Latin America Vials for COVID-19 Vaccine Revenue Market Share by Application (2018-2029)
Figure 82. Middle East, Africa and Latin America Vials for COVID-19 Vaccine Sales Quantity Share by Country (2018-2029)
Figure 83. Middle East, Africa and Latin America Vials for COVID-19 Vaccine Revenue Share by Country (2018-2029)
Figure 84. Brazil Vials for COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 85. Mexico Vials for COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 86. Turkey Vials for COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 87. Israel Vials for COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 88. GCC Countries Vials for COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 89. Vials for COVID-19 Vaccine Value Chain
Figure 90. Vials for COVID-19 Vaccine Production Process
Figure 91. Channels of Distribution (Direct Vs Distribution)
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed